Description

Relugolix is an oral medication used primarily for the treatment of prostate cancer and other hormone-sensitive conditions. It functions as a gonadotropin-releasing hormone (GnRH) receptor antagonist, effectively reducing testosterone levels in the body.

Interpreter Notes

Interpreters should be aware that the term 'Relugolix' may be accompanied by various brand names or formulations in different contexts. It is important to maintain a formal register and avoid colloquial terms. There are no widely recognized colloquial alternatives, but interpreters should ensure clarity when discussing its use in cancer treatment.

Example Sentences

EN: The doctor prescribed Relugolix to help manage the patient's prostate cancer.

ES: El médico recetó Relugolix para ayudar a controlar el cáncer de próstata del paciente.

Common Interpreter Mistakes

Confusing Relugolix with other GnRH antagonists; mispronouncing it as 'relugolix' instead of the correct pronunciation; using informal terms instead of the clinical term.